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Background: Chromosome 17q21.31 contains a common inversion polymorphism of approximately 900 kb in
populations with European ancestry. Two divergent MAPT haplotypes, H1 and H2 are described with distinct linkage
disequilibrium patterns across the region reflecting the inversion status at this locus. The MAPT H1 haplotype has
been associated with progressive supranuclear palsy, corticobasal degeneration, Parkinson’s disease and Alzheimer’s
disease, while the H2 is linked to recurrent deletion events associated with the 17q21.31 microdeletion syndrome, a
disease characterized by developmental delay and learning disability.
Results: In this study, we investigate the effect of the inversion on the expression of genes in the 17q21.31 region.
We find the expression of several genes in and at the borders of the inversion to be affected; specific either to
whole blood or different regions of the human brain. The H1 haplotype was found to be associated with an
increased expression of LRRC37A4, PLEKH1M and MAPT. In contrast, a decreased expression of MGC57346, LRRC37A
and CRHR1 was associated with H1.
Conclusions: Studies thus far have focused on the expression of MAPT in the inversion region. However, our results
show that the inversion status affects expression of other genes in the 17q21.31 region as well. Given the link
between the inversion status and different neurological diseases, these genes may also be involved in disease
pathology, possibly in a tissue-specific manner.Background
The chromosomal band 17q21.31 contains a common
inversion polymorphism linked with neurodegenerative
diseases including progressive supranuclear palsy [1],
corticobasal degeneration [2], Parkinson’s disease [3],
and Alzheimer’s disease [4]. This inversion of approxi-
mately 900 kb is mostly present in populations with
European ancestry (Figure 1) [5,6]. This region contains
a number of genes, including corticotrophin releasing
hormone receptor 1 (CRHR1) and microtubule-
associated protein tau (MAPT). Two divergent MAPT
haplotypes, H1 and H2 are described with distinct* Correspondence: rophoff@mednet.ucla.edu
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reproduction in any medium, provided the orlinkage disequilibrium patterns across the region reflect-
ing the inversion status at this locus. The H2 haplotype
is inverted and is relatively common in Europeans
(~20%), however, almost absent in African and Asian
populations. This configuration is associated with fe-
cundity and appears to be under positive selection in
European populations [6].
Specific H1 haplotypes are associated with the neuro-
degenerative disorders, whereas the H2 haplotype is
linked to recurrent deletion events resulting in the
17q21.31 microdeletion syndrome, characterized by de-
velopmental delay and learning disability [7,8]. The H1
haplotype is linked with an increased expression of
MAPT, resulting in overproduction and aggregation of
hyperphosphorylated protein Tau in neuronal cell bod-
ies, which is linked to disease pathology of a number of
neurodegenerative disorders [9-12]. However, little isl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 17q21.31 inversion region. Schematic overview of the 17q21.31 region in the direction orientation corresponding with the H1
haplotype and the cis-region of 1 MB each side (Chr17:39,899,921-42,989,253; UCSC browser, March 2006 assembly, http://genome.ucsc.edu). Pink
segment shows the 40850001–41850000 region. Expression of genes colored red is increased in the H1/H1 haplotype (LRRC37A4 in blood,
PLEKHM1 and MAPT in one or more brain regions), those in green decreased (MGC57346 in blood, CRHR1 and LRRC37A in one or more
brain regions).
Figure 2 The 17q21.31 inversion haplotypes in the whole
blood dataset. Scatterplot of PC1 and PC2 values in the 17q21.31
region (constructed using 38 SNPs in the 40,850,001-41,850,000
interval). Individuals fall into three clusters, representing H1/H1
(blue), H1/H2 (green) and H2/H2 (orange).
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genes in the region.
In this study we used single nucleotide polymorphism
(SNP) genotype data to reconstruct inversion haplotypes
in the chromosome 17q21.31 region and studied the ef-
fect of the inversion status on gene expression of all
known genes in the region in whole blood and different
regions of the human brain.
Results
Regulation of expression in whole blood
A principal component analysis (PCA) was applied to 38
SNPs in the 40,850,001-41,850,000 region on chromo-
some 17. The first principal component (PC1) represents
the 17q21.31 inversion genotypes homozygous H1, het-
erozygous H1/H2 and homozygous H2/H2. Of the 437
individuals, 6 were excluded because of ambiguity in
master genotype call (>3SD from mean PC1 value of
genotype cluster). This resulted in three distinct clusters
of individuals, representing H1/H1 (252 individuals,
59%), H1/H2 (160 individuals, 37%) and H2/H2 (19 indi-
viduals, 4%) genotypes (Hardy Weinberg p= 0.31),
depicted in Figure 2. For 22 of the 56 genes in the re-
gion, 28 gene expression probes were available in the
blood dataset (full list in Additional file 1: Table S1).
A linear regression analysis showed a positive associ-
ation of LRRC37A4 (B = 0.37, p= 1.4 × 10-55, Figure 3)
with the number of H1 alleles. In contrast, MGC57346
was negatively associated with the H1/H1 genotype
(B =−0.19, p= 1.2 × 10-16, Figure 3) Results are given in
Table 1. We did not detect expression of the MAPT gene
in blood.Regulation of expression in human brain
We consulted a publically available human brain expres-
sion dataset consisting of frontal cortex, temporal cortex,
cerebellum and pons of 144 individuals [13]. Master
genotypes of the chromosome 17q21.31 inversion were
reconstructed using PC1 values of 60 SNPs in the
Figure 3 Expression changes associated with the 17q21.31
inversion haplotypes in the whole blood dataset. Barplot shows
the mean log2 expression values (error bars represent standard
deviation) of LRRC37A4 and MGC57346 for H1/H1, H1/H2 and
H2/H2 genotypes.
Table 1 Expression probes associated with 17q21.31
inversion region in different datasets
Whole blood
Probe ID t B (95% CI) p
LRRC37A4 ILMN_2393693 18.29 0.37 (0.33, 0.41) 1.4 x 10-55
MGC57346 ILMN_1784428 −8.63 −0.19 (−0.24, -0.15) 1.2 x 10-16
PLEKHM1 ILMN_1709549 ns ns ns
MAPT dt dt dt dt
LRRC37A ILMN_1783673 ns ns ns
CRHR1 ILMN_1732426 ns ns ns
Cerebellum
Probe ID t B (95% CI) p
LRRC37A4 n/a n/a n/a n/a
MGC57346 n/a n/a n/a n/a
PLEKHM1 ILMN_1709549 4.98 0.18 (0.11, 0.25) 1.9 x 10-6
MAPT ILMN_1710903 6.01 0.36 (0.24, 0.48) 1.6 x 10-8
LRRC37A ILMN_1783673 ns ns ns
CRHR1 ILMN_1753706 −4.18 −0.09 (−0.13, -0.05) 5.2 x 10-5
Frontal Cortex
Probe ID t B (95% CI) p
LRRC37A4 n/a n/a n/a n/a
MGC57346 n/a n/a n/a n/a
PLEKHM1 ILMN_1709549 ns ns ns
MAPT ILMN_1710903 4.76 0.34 (0.20, 0.48) 4.8 x 10-6
LRRC37A ILMN_1783673 −7.92 −0.25 (−0.32, -0.19) 7.4 x 10-13
CRHR1 ILMN_1753706 dt dt dt
Temporal Cortex
Probe ID t B (95% CI) p
LRRC37A4 n/a n/a n/a n/a
MGC57346 n/a n/a n/a n/a
PLEKHM1 ILMN_1709549 n/a ns ns
MAPT ILMN_1710903 ns ns ns
LRRC37A ILMN_1783673 −9.15 −0.29 (−0.35, -0.23) 6.9 x 10-16
CRHR1 ILMN_1753706 dt dt dt
Pons
Probe ID t B (95% CI) p
LRRC37A4 n/a n/a n/a n/a
MGC57346 n/a n/a n/a n/a
PLEKHM1 ILMN_1709549 ns ns ns
MAPT ILMN_1710903 ns ns ns
LRRC37A ILMN_1783673 −6.03 −0.17 (−0.23, -0.12) 1.5 x 10-8
CRHR1 ILMN_1753706 dt dt dt
The genes found to be associated to the 17q21.31 inversion haplotypes are listed
in the first column with their corresponding probe IDs (Illumina H12.v3 in blood
and Illumina H8.v2 in brain). The genes have been tested in two datasets and
results of linear regression are given, t, B (with 95% CI) and p-values. The B values
indicate the actual change in expression associated with each copy of the H1 allele
(0, 1 or 2). The corresponding unadjusted p-values are listed when significant. Not
all genes were available or detected in each dataset; n/a=not available on array,
dt =did not meet detection threshold in tissue, ns=not significant. All probes for
the genes in the 17q21.31 region are listed in Additional file 1: Table S1.
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distinct clusters of individuals, representing H1/H1 (77
individuals, 53%), H1/H2 (54 individuals, 38%) and H2/
H2 (13 individuals, 9%) genotypes (Hardy Weinberg
p= 0.43).
For 36 of the 56 genes in the inversion region, 40 ex-
pression probes were available in every brain area (full
list in Additional file 1: Table S1). A linear regression
analysis of allele dosage was performed for each brain
area separately (Table 1). In line with literature, we
found a higher expression of MAPT to be associated
with the H1/H1 genotype in frontal cortex (B = 0.34,
p= 4.8 × 10-6) and cerebellum (B= 0.36, p= 1.6 × 10-8).
In addition, the H1/H1 genotype was also associated
with increased expression of PLEKHM1 in cerebellum
(B = 0.18, p= 1.9 × 10-6). In contrast, lower expression of
CRHR1 was associated with this genotype in cerebellum
(B =−0.89, p= 5.2 × 10-5), while undetected in the other
brain regions. Finally, decreased expression of LRRC37A
was found to be associated with the H1/H1 genotype
in frontal cortex (B =−0.25, p= 7.4 × 10-13), temporal
cortex (B =−0.29, p= 6.9 × 10-16) and pons (B =−0.17,
p= 1.5 × 10-8).
No polymorphic SNPs were detected in the probe se-
quence that could have confounded the hybridization
signal. When aligning the LRRC37A probe sequence (50
nucleotides, identical on H12.v3 and H8.v2 Illumina bea-
darrays) to refseq RNA sequences (NCBI BLAST; http://
blast.ncbi.nlm.nih.gov/Blast.cgi), it was found that this
probe aligns significantly with not only LRRC37A
(100%), but also LRRC37A2 (100%), LRRC37A3 (100%)
and LRRC37A4 (94%). Therefore, the strong association
can be the result of non-specific binding to more than
one target gene in this gene family. Alignment of all
other significant probes sequences, including LRRC37A4,
did not suggest non-specific binding.
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The chromosome 17q21.31 inversion of the MAPT
(microtubule-associated protein Tau) locus represents
one of the most structurally complex and evolutionarily
dynamic regions of the genome [14]. The distinct clades
of haplotypes (H1 and H2) represent the direct and
inverted orientation of the inversion, each with different
functional impacts. Specific H1 haplotypes are asso-
ciated with neurodegenerative disorders such as pro-
gressive supranuclear palsy [1] and Parkinson’s disease
[3], whereas the H2 haplotype is associated with recur-
rent microdeletions resulting in the 17q21.31 microde-
letion syndrome [7,8]. Neurodegenerative diseases
associated with the H1 haplotype exhibit aggregation
of hyperphosphorylated protein Tau in neuronal cell
bodies [2,12].
Gene expression differences have been described for
MAPT, but there has been no systematic approach to
study the effect of inversion status on expression of the
other genes at this locus. We used principal component
analysis to identify inversion haplotypes at chromosome
17q21.31, and observed that the effect of inversion status
is not limited to MAPT expression levels, but also affects
several other genes in the 17q21.31 region. In line with
literature, we found increased expression of MAPT to be
associated with the number of H1 alleles in brain. How-
ever, we only observed this in frontal cortex and cerebel-
lum, suggesting that regulation of this gene may differ
between brain regions. A previous study identified a spe-
cific sequence variant in MAPT (htSNP167/rs242557) in
the 17q21.31 region on the H1 haplotype regulating the
expression of MAPT in neuronal and non-neuronal cell
lines [11]. In this study we focused on the effect of the
entire inversion on gene expression with use of a robust
principal component analysis strategy. Genotype data of
this particular SNP was available in the brain dataset
but was not significantly associated with gene expression
values.
Importantly, we observed that genes other than MAPT
are functionally regulated by the inversion haplotypes as
well and may therefore be of importance in diseases
associated with the inversion region.
The expression of CRHR1 (corticotrophin releasing
hormone receptor 1) is significantly decreased in the
H1/H1 haplotype and that of PLEKHM1 (pleckstrin
homology domain containing, family M (with RUN do-
main) member 1) increased. These associations were
found in cerebellum only. The PLEKHM1 gene is
involved in osteopertrosis by affecting vesicular trans-
port and therefore osteoclast-osteoblast cross-talk [15].
Currently there is no functional data available on
MGC57346 (hypothetical protein LOC401884) that was
found to be differentially expressed due to inversion sta-
tus in whole blood. MGC57346 consists of 4 exons ofwhich 3 are shared with the long isoform of CRHR1
(Figure 1). It is therefore possible that these are different
splice forms of a single gene, which would suggest that
the concurrent association findings with inversion status
represent a single event. The fact that directionality of
MGC57346 expression in blood and CRHR1 expression
in cerebellum is the same in this study supports this
view. The CRHR gene is a critical part of the
hypothalamic-pituitary-adrenal (HPA) axis that mediates
stress response and has been implicated in the patho-
physiology of stress-related psychiatric disorders. Of the
two receptors in this system (CRHR1 and CRHR2), over-
activity of CRHR1 in anxiety and depression has been a
consistent finding in animal studies [16]. In human,
there is evidence for an interaction of CRHR1 function
and stressful life events on vulnerability to depression
and alcoholism through regulation of HPA-axis and pos-
sibly additional interaction with serotonin transporter
loci [17]. In addition, multiple sclerosis (MS) has been
associated to HPA-axis activity, specifically genetic var-
iants in CRHR1 [18]. We find increased expression of
CRHR1 associated with H2 configuration, suggesting
that CRHR1 activity and/or stress response might also
be altered in or contributing to the H2 related pheno-
types such as developmental delay and learning
disability.
There is no functional data available for leucine
rich repeat containing 37, member A4 (LRRC37A4)
expressed in whole blood and LRRC37A (leucine rich re-
peat containing 37A) expressed in brain. For both genes
we observed a significant association with inversion sta-
tus, however, with opposite effects. It is important to
note that the LRRC37 gene family is located at either in-
version breakpoints and is therefore likely to be affected
by copy number variation that are associated with
17q21.31 inversion status [14] (Figure 1). Of the LRRC37
family, member A4 (LRRC37A4) in particular has been
shown to be most variable in copy number [19]. For
these reasons, the association between inversion status
and gene expression levels of these genes could be en-
tirely due to differences in copy number linked to H1
and H2 haplotypes.
A recent study finds a strong association between
germline hypomethylation and genomic instability, de-
scribing that DNA methylation deserts are highly
enriched for structural rearrangements [20]. The authors
report that rare CNVs that are associated with several
neuropsychiatric disorders are significantly linked with
local hypomethylation. In fact, germline hypomethyla-
tion seems to play a more important role in chromo-
somal rearrangement than the presence of segmental
duplications. Future studies should address whether in-
version status of the 17q21.31 region can be linked to
(large-scale) changes in epigenetic tags.
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In conclusion, our results indicate that the chromosome
17q21.31 inversion polymorphism associated with sev-
eral neurodegenerative disorders affects the expression
of multiple genes besides MAPT in a tissue-specific
manner. It is therefore likely that these other genes may




The whole blood dataset consisting of 437 healthy con-
trols is described elsewhere [21,22]. In short, this data
set consists of 244 males and 193 females with a mean
age of 62 years, who where recruited as controls in a
genetic study of amyotrophic lateral sclerosis. These
control subjects were selected for being in good general
health and unaffected with neurological and neurode-
generative diseases. Genotypes were generated on the
Illumina 370 k chip according to manufacturers’ proto-
col at deCODE genetics in Iceland. QC included missing
genotypes per individual <0.05, genotype rate per SNP
>0.05, MAF >0.05, Hardy Weinberg p<0.00001. Gene ex-
pression data for this control dataset was generated
using the Illumina H-12.v3 beadarray and quantile nor-
malized and log2 transformed using the PreprocessCore
package in R [23]. Expression probes were filtered for a
mean detection value > 0.90.
Brain datasets
We consulted a publically available brain expression
dataset of 144 individuals [13]. Gene expression data
was generated on Illumina H-8.v2 beadarrays (GEO;
GSE15745) and genotype data on Illumina 550 k chips
(dbGAP; phs000249.v1.p1). Data are available for four
different brain regions; cerebellum, frontal cortex, tem-
poral cortex and pons. Data was log2 transformed and
quantile normalized using the Lumi package for R [24].
Expression data was filtered for each brain region separ-
ately with a detection p-value threshold of 0.01.
Principal component analysis
We applied a principal component analysis (PCA) using
SNP data to reconstruct the inversion genotypes homo-
zygous H1, heterozygous H1/H2, and homozygous H2.
The first two principal components (PC1 and PC2) were
calculated with genotypes numerically encoded as m/
m= 0, m/M=1, M/M=2, where m and M are minor
and major alleles, respectively, in the 17q21.31 region;
40,850,001-41,850,000 (corresponding to coordinates in
UCSC assembly March 2006; http://genome.ucsc.edu)
[8]. We centered and normalized the genotype matrix
and used it for PCA as described by Price et al. [25].Linear regression
A linear regression analysis of allele dosage (H1/H1= 2,
H1/H2= 1 and H2/H2= 0) was performed on transcripts
in the 17q21.31 cis-region; defined as 1 MB on either
side of the inversion (39,899,921-42,989,253, Figure 1),
containing 56 genes (Refseq genes from UCSC browser,
March 2006 assembly; http://genome.ucsc.edu) listed in
Additional file 1: Table S1. In the whole blood dataset,
age and gender were taken covariates. In brain, covari-
ates also included post-mortem interval, brain bank and
hybridization batch. We report the unadjusted p-value
and B value, indicating the actual change in expression
associated with each copy of the H1 allele (0, 1 or 2).
Bonferroni correction was applied to determine signifi-
cance thresholds for the number of probes tested;
p < 0.05/28 = 0.0018 for the whole blood dataset and
p < 0.05/40 = 0.0017 for each brain region, assuming in-
dependence between regions.
Significant expression probes were subsequently tested
for common polymorphic SNPs in the 50-mer probe
sequence based on genomic location (provided by Illu-
mina) and Hapmap SNPs release 27. The threshold for
common SNPs is minor allele frequency (MAF) >1%.Additional file
Additional file 1: Table S1. This table contains a list of genes in the
17q21.31 region and the expression probes for these genes in both
datasets. ProbeIDs colored red are expressed above detection level in the
corresponding dataset. Black probes represent probes available on the
array, but not detectable in the tissue studied.
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